Institutional investors purchased a net $601.1 thousand shares of GENT during the quarter ended September 2013. This may signal that the smart money is gaining interest in this company as the 52.16% of the shares outstanding that institutional investors hold is among the lowest in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
PAULSON & CO., INC. Bought 965.5 Thousand shares of Gentium SpA
OPALEYE MANAGEMENT, INC. Bought 505.0 Thousand shares of Gentium SpA
POINTSTATE CAPITAL LP Bought 380.0 Thousand shares of Gentium SpA